Meanwhile, this study also emphasizes that the high proportion of genetically undetermined G6PD deficient individuals really necessitates enzyme activity-based diagnosis of G6PD deficiency before deciding on safety of primaquine treatment. This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.